InvestorsHub Logo
Followers 4
Posts 2010
Boards Moderated 0
Alias Born 09/19/2008

Re: xrymd post# 9374

Monday, 03/17/2014 10:21:46 AM

Monday, March 17, 2014 10:21:46 AM

Post# of 12138
I wouldn't even speculate at this time. That being stated, as shareholders we can see trends developing via the financial statements.
The last 3 quarters have seen total revenues exceed cost of revenues, as well, we saw a double in account receivables from the prior quarter. The pop in receivables is something of interest. Is Pfizer/Zoetis finally kicking in, or is there something we don't know.


If and when CYRX receives additional capital, how will it be allocated. It would be nice to see a reduction in current liabilities. If the liquidity ratio could be in the area of 1 or above, that would be extremely bullish.


In order to really get a feel for analyzing cash flow, we need to see a reduction in operating income or loss, and we haven't as of yet. That number continues to stay stagnant.






Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News